219 related articles for article (PubMed ID: 9582997)
1. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study.
Bertolino A; Callicott JH; Elman I; Mattay VS; Tedeschi G; Frank JA; Breier A; Weinberger DR
Biol Psychiatry; 1998 May; 43(9):641-8. PubMed ID: 9582997
[TBL] [Abstract][Full Text] [Related]
2. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.
Bertolino A; Kumra S; Callicott JH; Mattay VS; Lestz RM; Jacobsen L; Barnett IS; Duyn JH; Frank JA; Rapoport JL; Weinberger DR
Am J Psychiatry; 1998 Oct; 155(10):1376-83. PubMed ID: 9766769
[TBL] [Abstract][Full Text] [Related]
3. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.
Bertolino A; Nawroz S; Mattay VS; Barnett AS; Duyn JH; Moonen CT; Frank JA; Tedeschi G; Weinberger DR
Am J Psychiatry; 1996 Dec; 153(12):1554-63. PubMed ID: 8942451
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia.
Bertolino A; Callicott JH; Nawroz S; Mattay VS; Duyn JH; Tedeschi G; Frank JA; Weinberger DR
Neuropsychopharmacology; 1998 Jan; 18(1):1-9. PubMed ID: 9408913
[TBL] [Abstract][Full Text] [Related]
5. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging.
Bertolino A; Frye M; Callicott JH; Mattay VS; Rakow R; Shelton-Repella J; Post R; Weinberger DR
Biol Psychiatry; 2003 May; 53(10):906-13. PubMed ID: 12742678
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.
Blasi G; Bertolino A; Brudaglio F; Sciota D; Altamura M; Antonucci N; Scarabino T; Weinberger DR; Nardini M
Psychiatry Res; 2004 Jul; 131(2):95-105. PubMed ID: 15313516
[TBL] [Abstract][Full Text] [Related]
7. Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype.
Callicott JH; Egan MF; Bertolino A; Mattay VS; Langheim FJ; Frank JA; Weinberger DR
Biol Psychiatry; 1998 Nov; 44(10):941-50. PubMed ID: 9821558
[TBL] [Abstract][Full Text] [Related]
8. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.
Sigmundsson T; Maier M; Toone BK; Williams SC; Simmons A; Greenwood K; Ron MA
Schizophr Res; 2003 Nov; 64(1):63-71. PubMed ID: 14511802
[TBL] [Abstract][Full Text] [Related]
9. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
10. Reduced hippocampal N-acetylaspartate without volume loss in schizophrenia.
Deicken RF; Pegues M; Amend D
Schizophr Res; 1999 Jun; 37(3):217-23. PubMed ID: 10403193
[TBL] [Abstract][Full Text] [Related]
11. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients.
Brambilla P; Stanley JA; Nicoletti MA; Sassi RB; Mallinger AG; Frank E; Kupfer D; Keshavan MS; Soares JC
J Affect Disord; 2005 May; 86(1):61-7. PubMed ID: 15820271
[TBL] [Abstract][Full Text] [Related]
12. Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.
Coughlin JM; Tanaka T; Marsman A; Wang H; Bonekamp S; Kim PK; Higgs C; Varvaris M; Edden RA; Pomper M; Schretlen D; Barker PB; Sawa A
Curr Mol Med; 2015; 15(2):176-83. PubMed ID: 25732147
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy.
Deicken RF; Zhou L; Schuff N; Fein G; Weiner MW
Biol Psychiatry; 1998 Apr; 43(7):483-8. PubMed ID: 9547926
[TBL] [Abstract][Full Text] [Related]
14. Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: a proton magnetic resonance spectroscopic imaging study.
Bertolino A; Saunders RC; Mattay VS; Bachevalier J; Frank JA; Weinberger DR
Cereb Cortex; 1997 Dec; 7(8):740-8. PubMed ID: 9408038
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotic drug treatment for 6 months restores N-acetylaspartate in left prefrontal cortex and left thalamus of first-episode patients with early onset schizophrenia: A magnetic resonance spectroscopy study.
Gan JL; Cheng ZX; Duan HF; Yang JM; Zhu XQ; Gao CY
Psychiatry Res; 2014 Jul; 223(1):23-7. PubMed ID: 24831926
[TBL] [Abstract][Full Text] [Related]
16. [Proton magnetic resonance spectroscopic imaging of the hippocampus in schizophrenia patients before and after surgery].
Chang HM; Qi ST; Yang KJ; Wang KW; Guo ZW; Wang H
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):996-8. PubMed ID: 19460730
[TBL] [Abstract][Full Text] [Related]
17. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
[TBL] [Abstract][Full Text] [Related]
18. The impact of endurance training and table soccer on brain metabolites in schizophrenia.
Rauchmann BS; Ghaseminejad F; Keeser D; Keller-Varady K; Schneider-Axmann T; Takahashi S; Karali T; Helms G; Dechent P; Maurus I; Hasan A; Wobrock T; Ertl-Wagner B; Schmitt A; Malchow B; Falkai P
Brain Imaging Behav; 2020 Apr; 14(2):515-526. PubMed ID: 31686308
[TBL] [Abstract][Full Text] [Related]
19. Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla.
Stern AJ; Savostyanova AA; Goldman A; Barnett AS; van der Veen JW; Callicott JH; Mattay VS; Weinberger DR; Marenco S
Biol Psychiatry; 2008 Nov; 64(10):856-62. PubMed ID: 18707679
[TBL] [Abstract][Full Text] [Related]
20. Whole-brain proton MR spectroscopic imaging in Parkinson's disease.
Levin BE; Katzen HL; Maudsley A; Post J; Myerson C; Govind V; Nahab F; Scanlon B; Mittel A
J Neuroimaging; 2014; 24(1):39-44. PubMed ID: 23228009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
